Literature DB >> 30829416

Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patients.

Sarah K L Moore1, Katherine H Chau2, Salma Chaudhary2, Geoffrey Rubin2, Joseph Bayne1, Uma Mahesh R Avula2, Daniel Y Wang3, Carmine Sorbera2, Jose Dizon2, Angelo Biviano2, Marc Waase2, Vivek Iyer4, Isaac George5, Susheel K Kodali2, Tamim M Nazif2, Hasan Garan2, Elaine Y Wan2.   

Abstract

BACKGROUND: Leadless pacemakers (LPMs) have been shown to have lower postoperative complications than traditional permanent pacemakers but there have been no studies on the outcomes of LPMs in patients with transcatheter heart valve replacements (THVRs). This study determined outcomes of LPMs compared to transvenous single-chamber pacemakers (SCPs) post-THVR.
METHODS: This is a retrospective single-center study including 10 patients who received LPMs post-THVR between February 2017 and August 2018 and a comparison group of 23 patients who received SCP post-THVR between July 2008 and August 2018. LPM or SCP was implanted at the discretion of electrophysiologists for atrial fibrillation with slow ventricular response or sinus node dysfunction with need for single-chamber pacing only.
RESULTS: LPMs were associated with decreased tricuspid regurgitation (P = 0.04) and decreased blood loss during implantation (7.5 ± 2.5 cc for LPMs vs 16.8 ± 3.2 cc for SCPs, P = 0.03). Five LPM patients had devices positioned in the right ventricular septum as seen on transthoracic echocardiogram. Frequency of ventricular pacing was similar between LPM and SCP groups. In the LPM group, one case was complicated by a pseudoaneurysm and one death was due to noncardiac causes. There was one pneumothorax and one pocket infection in the SCP group.
CONCLUSIONS: In this small retrospective study, LPMs were feasible post-THVR and found to perform as well as SCPs, had less intraprocedural blood loss, and were associated with less tricuspid regurgitation. Further, larger studies are required to follow longer-term outcomes and complications.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  leadless pacemaker; permanent pacemaker; single-chamber pacemaker; transcatheter heart valve replacement; tricuspid regurgitation

Mesh:

Year:  2019        PMID: 30829416      PMCID: PMC6476663          DOI: 10.1111/pace.13648

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  23 in total

1.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

2.  Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.

Authors:  Vivek Y Reddy; Derek V Exner; Daniel J Cantillon; Rahul Doshi; T Jared Bunch; Gery F Tomassoni; Paul A Friedman; N A Mark Estes; John Ip; Imran Niazi; Kenneth Plunkitt; Rajesh Banker; James Porterfield; James E Ip; Srinivas R Dukkipati
Journal:  N Engl J Med       Date:  2015-08-30       Impact factor: 91.245

3.  Permanent direct his bundle pacing does not induce ventricular dyssynchrony unlike conventional right ventricular apical pacing. An intrapatient acute comparison study.

Authors:  Domenico Catanzariti; Massimiliano Maines; Claudio Cemin; Gianpaolo Broso; Tiziana Marotta; Giuseppe Vergara
Journal:  J Interv Card Electrophysiol       Date:  2006-11-18       Impact factor: 1.900

4.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

5.  Transcatheter Leadless Pacemaker Implantation for Complete Heart Block Following CoreValve Transcatheter Aortic Valve Replacement.

Authors:  Marat Fudim; Joseph L Fredi; Stephen K Ball; Christopher R Ellis
Journal:  J Cardiovasc Electrophysiol       Date:  2015-08-07

6.  Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial.

Authors:  Reinoud E Knops; Fleur V Y Tjong; Petr Neuzil; Johannes Sperzel; Marc A Miller; Jan Petru; Jaroslav Simon; Lucie Sediva; Joris R de Groot; Srinivas R Dukkipati; Jacob S Koruth; Arthur A M Wilde; Josef Kautzner; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2015-04-21       Impact factor: 24.094

7.  Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.

Authors:  Marco Barbanti; Ronald K Binder; Danny Dvir; John Tan; Melanie Freeman; Christopher R Thompson; Anson Cheung; David A Wood; Jonathon Leipsic; John G Webb
Journal:  Catheter Cardiovasc Interv       Date:  2014-04-30       Impact factor: 2.692

8.  Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study.

Authors:  Erik O Udo; Nicolaas P A Zuithoff; Norbert M van Hemel; Carel C de Cock; Thijs Hendriks; Pieter A Doevendans; Karel G M Moons
Journal:  Heart Rhythm       Date:  2011-12-17       Impact factor: 6.343

9.  Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.

Authors:  Grace Lin; Rick A Nishimura; Heidi M Connolly; Joseph A Dearani; Thoralf M Sundt; David L Hayes
Journal:  J Am Coll Cardiol       Date:  2005-05-17       Impact factor: 24.094

10.  Permanent leadless cardiac pacing: results of the LEADLESS trial.

Authors:  Vivek Y Reddy; Reinoud E Knops; Johannes Sperzel; Marc A Miller; Jan Petru; Jaroslav Simon; Lucie Sediva; Joris R de Groot; Fleur V Y Tjong; Peter Jacobson; Alan Ostrosff; Srinivas R Dukkipati; Jacob S Koruth; Arthur A M Wilde; Josef Kautzner; Petr Neuzil
Journal:  Circulation       Date:  2014-03-24       Impact factor: 29.690

View more
  2 in total

1.  One-year pacing dependency after pacemaker implantation in patients undergoing transcatheter aortic valve implantation: Systematic review and meta-analysis.

Authors:  Justine M Ravaux; Michele Di Mauro; Kevin Vernooy; Arnoud W Van't Hof; Leo Veenstra; Suzanne Kats; Jos G Maessen; Roberto Lorusso
Journal:  JTCVS Open       Date:  2021-02-12

Review 2.  Evolution of tricuspid valve regurgitation after implantation of a leadless pacemaker: A single center experience, systematic review, and meta-analysis.

Authors:  Andreas Haeberlin; Joanna Bartkowiak; Nicolas Brugger; Hildegard Tanner; Elaine Wan; Samuel H Baldinger; Jens Seiler; Antonio Madaffari; Gregor Thalmann; Helge Servatius; Laurent Roten; Fabian Noti; Tobias Reichlin
Journal:  J Cardiovasc Electrophysiol       Date:  2022-06-07       Impact factor: 2.942

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.